DexCom received a warning letter from the Food and Drug Administration following inspections of its San Diego and Mesa, Ariz.

Medical device maker Dexcom said it has received a warning letter from the U.S. Food and Drug Administration following ...

Dexcom (Nadsaq:DXCM) announced today that it received a warning letter from the FDA following inspections of two company ...

DexCom (NasdaqGS:DXCM) recently received a warning letter from the FDA, which pointed out issues in manufacturing processes and quality management. While these regulatory developments did not impact ...

In a regulatory filing, DexCom (DXCM) disclosed that on March 4, the company received a warning letter from the U.S. FDA following inspections ...

The FDA cited issues with DexCom’s response to prior inspection findings, known as Form 483 observations. The inspections took place at the San Diego facility between October 21 and November 7, 2024, ...

The U.S. Department of Agriculture has dissolved two key food safety advisory committees, sparking concern over government ...

EST DexCom (DXCM) falls 7% to $71.99 after receiving warning letter from FDADiscover the Best Stocks and Maximize Your Portfolio: See ...

The latest health news includes Johnson & Johnson halting testing on a depression drug, USDA eliminating food safety advisory ...

Sitting before senators at his confirmation hearing to become commissioner of the FDA, Johns Hopkins surgeon and author ...

Really important to know we launched DexCom ONE+. It's a product that's predominantly ... So as soon as we have both the FDA coverage, as well as the appropriate amount of insurance coverage ...